Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Journal of Biotechnology|February 28, 1997
Genetic engineering of a recombinant fusion possessing anti-tumor F(ab')2 and tumor necrosis factorJ Xiang, T Moyana, Y QiCancer Gene Therapy|August 5, 2000
Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transferJ Xiang, Y Chen, T MoyanaExperimental Cell Research|May 23, 1998
Elevated expression of the cdc25A protein phosphatase in colon cancerD Dixon, T Moyana, M J KingGastroenterology|December 1, 1995
Antibody-targeted lymphokine-activated killer cells inhibit liver micrometastases in severe combined immunodeficient miceY Qi, T Moyana, R Bresalier, et al.Immunology and Cell Biology|August 1, 1994
Single-chain antibody variable region-targeted interleukin-2 stimulates T cell killing of human colorectal carcinoma cellsJ Xiang, E Liu, T Moyana, et al.Cancer Gene Therapy|January 23, 1999
Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regressionP Wright, C Zheng, T Moyana, et al.Proteins|March 1, 1996
Identification of a decapeptide with the binding reactivity for tumor-associated TAG72 antigen from a phage displayed libraryJ Gui, T Moyana, B Malcolm, et al.Leukemia Research|September 5, 2001
Regression of engineered myeloma cells secreting interferon-gamma-inducing factor is mediated by both CD4(+)/CD8(+) T and natural killer cellsJ Xiang, Z Chen, H Huang, et al.Human Antibodies and Hybridomas|January 1, 1996
Targeting gamma interferon to tumor cells by a genetically engineered fusion protein secreted from myeloma cellsJ Xiang, Y Qi, D Cook, et al.Human Antibodies and Hybridomas|January 1, 1996
Characterization of anti-tumor immunity derived from the inoculation of myeloma cells secreting the fusion protein RM4/IFN-tauY Qi, T Moyana, Y Chen, et al.Pageof 4